• G-CSF prophylaxis following first occurrence• If neutropenia recurs, interrupt lenalidomide and monitor CBC weekly until ANC is ≥1000/μL• Stepwise 5 mg dose reduction. This evidence concerns the gene CSF3 and Decreased total neutrophil count.